Related Experiment Videos
Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing
I Cascino1, G Fiucci, G Papoff
1Department of Immunobiology, Institute of Cell Biology, National Research Council, Rome, Italy.
Abstract:
Fas/Apo-1 molecule is an apoptosis-signaling cell surface Ag belonging to the TNFR family. To investigate the possibility that soluble forms of the Fas receptor are expressed in human cells, we analyzed Fas mRNA transcripts obtained from activated peripheral mononuclear cells of healthy donors and from human tumor cell lines. We identified and characterized three human mRNA Fas variants: FasTMDel, FasDel2, and FasDel3. To determine whether the three transcripts were derived by alternative splicing, the Fas genomic intron/exon organization of the regions surrounding the deleted sequences was analyzed in Fas clones isolated from a human genomic library. Expression of the transcripts was studied in COS cells transiently transfected with the FasTMDel, FasDel2, and FasDel3 cDNAs. Immunocytochemical and in vitro apoptosis inhibition studies suggest that the transcripts are expressed as soluble Fas proteins that may play a functional role in the regulation of apoptosis.
Insights
Researchers discovered soluble Fas variants (FasTMDel, FasDel2, FasDel3) in human cells. These soluble Fas proteins, derived from alternative splicing, may regulate apoptosis signaling.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- The Fas/Apo-1 molecule is a cell surface antigen crucial for apoptosis signaling, belonging to the Tumor Necrosis Factor Receptor (TNFR) family.
- Understanding the expression and function of soluble forms of cell surface receptors is vital for comprehending cellular regulation.
Purpose of the Study:
- To investigate the existence and characteristics of soluble Fas receptor forms in human cells.
- To determine if identified Fas mRNA variants arise from alternative splicing and if they encode functional soluble proteins.
Main Methods:
- Analysis of Fas mRNA transcripts from activated peripheral blood mononuclear cells and human tumor cell lines.
- Isolation and characterization of Fas genomic clones to study intron/exon organization.
- Transient transfection of COS cells with Fas cDNA variants (FasTMDel, FasDel2, FasDel3).
- Immunocytochemical analysis and in vitro apoptosis inhibition assays.
Main Results:
- Identification and characterization of three distinct human mRNA Fas variants: FasTMDel, FasDel2, and FasDel3.
- Evidence suggesting these variants are generated through alternative splicing of the Fas gene.
- Demonstration of expression of these transcripts as soluble Fas proteins in transfected cells.
- Observation that these soluble Fas proteins may inhibit apoptosis.
Conclusions:
- Soluble forms of the Fas receptor are expressed in human cells, generated by alternative splicing.
- These soluble Fas proteins have the potential to modulate the Fas-mediated apoptosis pathway.
- Further research into the functional role of soluble Fas in apoptosis regulation is warranted.